Literature DB >> 10789924

Pediatric risk of mortality (PRISM) score in meningococcal disease.

M J van Brakel1, A J van Vught, R J Gemke.   

Abstract

UNLABELLED: To assess the pediatric risk of mortality (PRISM) score as a prognostic scoring system in severe meningococcal disease, the files of 53 consecutive patients admitted to a tertiary pediatric intensive care with a clinical diagnosis of meningococcal disease and positive cultures from blood and/or cerebrospinal fluid were analysed. PRISM-score-based expected mortality was compared with observed mortality. Expected mortality in the whole study population was 29% while observed mortality was 19% (P<0.05). The highest expected and observed mortality was found in septicaemic patients without (documented) meningitis, while meningitis patients without septicaemia had the lowest mortality. All patients with a mortality risk below 18.3% (n = 29) survived whereas all those with a mortality risk of 65% or higher (n = 7) died. Of the 17 patients with a mortality risk between 18.3% and 63.9%, 14 survived and 3 died. The area under the receiver-operating characteristic (ROC) curve was 0.94, which is at least comparable with the best-performing meningococcal-disease-specific scoring systems.
CONCLUSION: The PRISM score is a useful generic measure of severity of illness in meningococcal disease and can be used to determine the effectiveness of different treatment strategies.

Entities:  

Mesh:

Year:  2000        PMID: 10789924     DOI: 10.1007/s004310050060

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  4 in total

1.  Mortality in severe meningococcal disease.

Authors:  K Thorburn; P Baines; A Thomson; C A Hart
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

2.  Use of a Mortality Prediction Model in Children on Mechanical Ventilation: A 5-Year Experience in a Tertiary University Hospital.

Authors:  Waleed H Albuali; Amal A Algamdi; Elham A Hasan; Mohammad H Al-Qahtani; Abdullah A Yousef; Mohammad A Al Ghamdi; Dalal K Bubshait; Mohammed S Alshahrani; Faisal O AlQurashi; Talal A Bou Shahmah; Bassam H Awary
Journal:  J Multidiscip Healthc       Date:  2020-11-11

3.  Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.

Authors:  François Fourrier; Francis Leclerc; Karl Aidan; Ahmed Sadik; Mercé Jourdain; Antoine Tournoys; Odile Noizet
Journal:  Intensive Care Med       Date:  2003-05-22       Impact factor: 17.440

4.  Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit.

Authors:  Graziela Araujo Costa; Arthur F Delgado; Alexandre Ferraro; Thelma Suely Okay
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.